Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Oncolytic Virotherapy · 2017
DOI: 10.2147/ov.s145262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncolytic Virotherapy, 2017. Verfasst von Raquel Yokoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, Department of Medicine, Mayo Clinic, Scottsdale. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology Oncology, Department of Medicine, Mayo Clinic, Scottsdale.
- Department of Biomedical Engineering, Arizona State University, Tempe.
- Division of Vascular and Interventional Radiology, Department of Radiology, Mayo Clinic, Scottsdale, AZ.
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Zitieren
APA
Yokoda, R., Nagalo, B. M., Vernon, B., Oklu, R., Albadawi, H., DeLeon, T. T., Zhou, Y., Egan, J. B., Duda, D. G., & Borad, M. J. (2017). Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s145262
Vancouver
Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, et al. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virotherapy. 2017. doi:10.2147/ov.s145262
BibTeX
@article{Yokoda2017,
author = {Yokoda, Raquel and Nagalo, Bolni M and Vernon, Brent and Oklu, Rahmi and Albadawi, Hassan and DeLeon, Thomas T and Zhou, Yumei and Egan, Jan B and Duda, Dan G and Borad, Mitesh J},
title = {Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect},
journal = {Oncolytic Virotherapy},
year = {2017},
doi = {10.2147/ov.s145262}
}
EUVIMED